Prosecution Insights
Last updated: April 19, 2026

Biontech (2013237)

12 pending office actions • 5 clients

Portfolio Summary

12
Total Pending OAs
4
Final Rejections
8
Non-Final OAs

Client Portfolio (5 clients)

Client (Assignee)Pending OAs
BIONTECH SE 8
Biontech Delivery Technologies GmbH 1
BIONTECH SE 1
Tron-Translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-Universität Mainz Gg 1
BIONTECH SE 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18554947 RNA COMPOSITIONS COMPRISING A BUFFER SUBSTANCE AND METHODS FOR PREPARING, STORING AND USING THE SAME Biontech Delivery Technologies GmbH TATGE, LEXUS MARC 1637 Non-Final OA Oct 11, 2023
18283715 COMBINATION THERAPY WITH AN ANTI-CA19-9 ANTIBODY AND FOLFIRINOX IN THE TREATMENT OF CANCER BIONTECH SE JUEDES, AMY E 1644 Non-Final OA Sep 22, 2023
18266135 RNA MANUFACTURING BIONTECH SE ZAHORIK, AMANDA MARY 1636 Non-Final OA Jun 08, 2023
18036677 LNP COMPOSITIONS COMPRISING RNA AND METHODS FOR PREPARING, STORING AND USING THE SAME BIONTECH SE DACE DENITO, ALEXANDRA GERALDINE 1636 Non-Final OA May 12, 2023
18036676 ENHANCED FORMULATION STABILIZATION AND IMPROVED LYOPHILIZATION PROCESSES BIONTECH SE MACH, ANDRE 1615 Final Rejection May 12, 2023
18036681 PHARMACEUTICAL COMPOSITIONS COMPRISING PARTICLES AND MRNA AND METHODS FOR PREPARING AND STORING THE SAME BIONTECH SE LIPPERT, JOHN WILLIAM 1615 Non-Final OA May 12, 2023
18019787 BINDING AGENTS FOR CORONAVIRUS S PROTEIN BIONTECH SE JADHAO, SAMADHAN JAISING 1672 Non-Final OA Feb 03, 2023
18071705 RNA FORMULATION FOR IMMUNOTHERAPY BIONTECH SE SHOMER, ISAAC 1612 Final Rejection Nov 30, 2022
17915567 RNA COMPOSITIONS TARGETING CLAUDIN-18.2 BIONTECH SE LI, RUIXIANG 1674 Non-Final OA Sep 29, 2022
17539157 PREDICTING IMMUNOGENICITY OF T CELL EPITOPES Tron-Translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-Universität Mainz Gg FONSECA LOPEZ, FRANCINI ALVARENGA 1685 Non-Final OA Nov 30, 2021
17481781 CORONAVIRUS VACCINES AND METHODS OF USE BIONTECH SE STUART, CAREY ALEXANDER MC 1671 Final Rejection Sep 22, 2021
16318895 Selecting Neoepitopes as Disease-Specific Targets for Therapy with Enhanced Efficacy BIONTECH SE GODDARD, LAURA B 1642 Final Rejection Jan 18, 2019

Managing Biontech (2013237)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month